NexgenRX Inc. (NXG) - Total Liabilities

Latest as of September 2025: CA$30.91 Million CAD ≈ $22.36 Million USD

Based on the latest financial reports, NexgenRX Inc. (NXG) has total liabilities worth CA$30.91 Million CAD (≈ $22.36 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore NexgenRX Inc. strategic investment ratio to see how much of total assets are deployed in long-term investments.

NexgenRX Inc. - Total Liabilities Trend (2013–2024)

This chart illustrates how NexgenRX Inc.'s total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of NexgenRX Inc..

NexgenRX Inc. Competitors by Total Liabilities

The table below lists competitors of NexgenRX Inc. ranked by their total liabilities.

Company	Country	Total Liabilities
Dcon Products Public Company Limited BK:DCON	Thailand	฿1.10 Billion
Naos Emerging Opportunities Company Ltd AU:NCC	Australia	AU$23.36 Million
Chin Yang Chem KO:051630	Korea	₩21.85 Billion
Cubic Digital Technology Co Ltd SHE:300344	China	CN¥144.52 Million
Rubicon Organics Inc V:ROMJ	Canada	CA$24.41 Million
Nara Mold & Die Co. Ltd KQ:051490	Korea	₩170.73 Billion
Sungwoo Electronics Co. Ltd KQ:081580	Korea	₩46.22 Billion
Grand House Mulia Pt JK:HOMI	Indonesia	Rp47.63 Billion

Liability Composition Analysis (2013–2024)

This chart breaks down NexgenRX Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is NexgenRX Inc.'s balance sheet to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.11	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	3.73	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.79	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how NexgenRX Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for NexgenRX Inc. (2013–2024)

The table below shows the annual total liabilities of NexgenRX Inc. from 2013 to 2024.

Year	Total Liabilities	Change
2024-12-31	CA$22.84 Million ≈ $16.52 Million	+1.60%
2023-12-31	CA$22.48 Million ≈ $16.26 Million	+33.06%
2022-12-31	CA$16.90 Million ≈ $12.22 Million	-14.33%
2021-12-31	CA$19.72 Million ≈ $14.27 Million	0.00%
2020-12-31	CA$19.72 Million ≈ $14.27 Million	+1.91%
2019-12-31	CA$19.35 Million ≈ $14.00 Million	+20.46%
2018-12-31	CA$16.07 Million ≈ $11.62 Million	+108.48%
2017-12-31	CA$7.71 Million ≈ $5.57 Million	+3.75%
2016-12-31	CA$7.43 Million ≈ $5.37 Million	+11.78%
2015-12-31	CA$6.64 Million ≈ $4.81 Million	+462.28%
2014-12-31	CA$1.18 Million ≈ $854.86K	-13.94%
2013-12-31	CA$1.37 Million ≈ $993.35K	--

About NexgenRX Inc.

V:NXG Canada Health Information Services

Market Cap

$30.87 Million

CA$42.67 Million CAD

Market Cap Rank

#24689 Global

#946 in Canada

Share Price

CA$0.60

Change (1 day)

-1.64%

52-Week Range

CA$0.31 - CA$0.70

All Time High

CA$0.70